301
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

“For Me, It’s Having Something Meaningful”: Women’s Emotional Understandings of Sex and the Sexual Acceptability of Contraception

ORCID Icon, & ORCID Icon
 

ABSTRACT

While the sexual acceptability of contraception – or, the impact of contraceptive methods on individuals’ sexual experiences – is a growing area of research, less frequently do studies engage the importance of individual emotions around sex when it comes to perceptions of sexual acceptability. Building on Higgins and Smith’s model of sexual acceptability and drawing upon insights from the sociology of gender, we used qualitative interview data with 30 women in Utah (USA) to explore the importance of emotional understandings of sex for women’s assessments of the sexual acceptability of different contraceptives. Here we posit that emotional understandings of sex are not just individualistic – they are also structured by experiences with sexual partners and broader gendered expectations. This work adds insight into the importance of emotions in sexual acceptability and suggests the need for an amendment to Higgins and Smith’s model that reflects the synergistic nature of the micro/individual, meso/interactional, and macro factors related to sexual acceptability. We conclude that assessing the sexual acceptability of contraceptives requires a nuanced multi-level interaction framework.

Acknowledgments

We would like to thank Madeline Mulholland and Indigo Mason for their assistance with “” featured in this article.

Additional information

Funding

This study was funded in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Office of Research on Women’s Health through [R01 HD095661 and K12HD085852]. Other Support for the HER Salt Lake Contraceptive Initiative parent study comes from the Society of Family Planning Research Fund, the William and Flora Hewlett Foundation, and an anonymous foundation. The following companies contributed contraceptive products for the project: Bayer Women’s Healthcare, Merck & Co. Inc., and Cooper Pharmaceuticals (formerly Teva Pharmaceuticals).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.